Small cell lung cancer (SCLC) cells grown as xenografts that have developed resistance to ABT-737 show a reduction in BIM:BCL-2 complexes compared to sensitive cells [49]. This evidence concerns the gene BCL2L11 and small cell lung carcinoma.